YU46767B - POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA - Google Patents

POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA

Info

Publication number
YU46767B
YU46767B YU111988A YU111988A YU46767B YU 46767 B YU46767 B YU 46767B YU 111988 A YU111988 A YU 111988A YU 111988 A YU111988 A YU 111988A YU 46767 B YU46767 B YU 46767B
Authority
YU
Yugoslavia
Prior art keywords
alkyl
benzothieno
thiazine
carboxamide
dihydro
Prior art date
Application number
YU111988A
Other languages
English (en)
Other versions
YU111988A (en
Inventor
A. Marfat
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU111988A publication Critical patent/YU111988A/xx
Publication of YU46767B publication Critical patent/YU46767B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA, formule: ili njihovih farmaceutski prihvatljivih soli, u kojoj R1 predstavlja vodonik, halogen ili C1-C4alkil, R2 je vodonik ili C1-C4 alkil, a Ar je fenil ili fenil supstituisan sa jednim ili vise supstituenata odabranih izmedju C1-C4alkil, halogen, treifluorometil, nitro, hidroksil, halofenil ili C1-C4alkoksi, naznacen time, sto obuhvata reaguvanje jedinjenja formule R2NH2 u kojem je R2 kao sto je definisano sa prethodno hlorsulfonovanim jedinjenjem formule u kojem je R1 kao sto je prethodno odredjeno, kada nastaje jedinjenje formule III, ili sa jedinjenjem formule III; u kojem je R1 kao sto je prethodno odredjeno gradeci jedinjenje formule IV u kojem su R1 i R2 kao sto je odredjeno, pri cemu se gornje reakcije izvode u hlorovanom rastvaracu, pogodno u metilenhloridu ili dih-loretanu, na temperaturi od -20° do 50°C, pogodno na 0°C i pritisku od 0,1 do 10 bara, pogodno atmosferskom, koje se litiira, a dobijeni dianjon razlaze sa gasovitim ugljen dioksidom i reakciona smesa zakiseli dajuci jedinjenje formule V: u kojoj se R1 i R2 kao sto je prethodno odredjeno, pri cemu je rastvarac za reakciju litacije aprotican, pogodno etiletar, temperatura izmedju -50° i 50°C, pogodno -20° do 0°C, a pritisak izmedju 0,1 i 10 bara, pogodno atmosferski, sto se na jedinjenju formule V vrsi ciklodehidratacija uz nagradjivanje jedinjenja formule VI: u kojoj su R1 i R2 kao sto je prethodno odredjeno, u prisustvu kiseline, pogodno p-toluensulfonske kiseline, u rastvaracu kao sto je benzen, toluen ili ksilen, na temperaturi od oko -25° do oko 250°C, pogodno na temperaturi refluksa rastvaraca, i na pritisku od 0,1 do 10 bara, pogodno atmosferskom, i sto jedinjenje formule VI reaguje jedinjenjem formule ArNCO, u kojem je Ar kao sto je prethodno odredjeno u polarnom rastvaracu kao sto je dimetilsulfoksid ili dimetilfor-mamid, pri temperaturi od -20° do 100°C, pogodno na sobnoj temperaturi, i pritisku od 0,1 do 10 bara, pogodno atmosferskom, i sto se, po potrebi, dobijeno jedinjenje formule I konvertuje u far-maceutski prihvatljivu so. Prijava sadrzi jos 2 zavisna zahteva.
YU111988A 1987-06-10 1988-06-09 POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA YU46767B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (2)

Publication Number Publication Date
YU111988A YU111988A (en) 1989-12-31
YU46767B true YU46767B (sh) 1994-05-10

Family

ID=55448100

Family Applications (1)

Application Number Title Priority Date Filing Date
YU111988A YU46767B (sh) 1987-06-10 1988-06-09 POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA

Country Status (28)

Country Link
US (1) US4914101A (sh)
EP (1) EP0294994B1 (sh)
JP (1) JPH078874B2 (sh)
KR (1) KR900006758B1 (sh)
CN (1) CN1019576B (sh)
AT (1) ATE105561T1 (sh)
AU (1) AU593743B2 (sh)
CA (1) CA1300625C (sh)
CZ (1) CZ281857B6 (sh)
DD (1) DD281602A5 (sh)
DE (1) DE3889497T2 (sh)
DK (1) DK313388A (sh)
EG (1) EG18525A (sh)
ES (1) ES2051846T3 (sh)
FI (1) FI89802C (sh)
HU (1) HU203762B (sh)
IE (1) IE63214B1 (sh)
IL (1) IL86602A (sh)
MX (1) MX174093B (sh)
MY (1) MY103572A (sh)
NO (2) NO176277C (sh)
NZ (1) NZ224956A (sh)
PH (1) PH25187A (sh)
PL (1) PL158994B1 (sh)
PT (1) PT87678B (sh)
WO (1) WO1988009793A1 (sh)
YU (1) YU46767B (sh)
ZA (1) ZA884115B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007970A1 (en) * 1989-11-30 1991-06-13 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives

Also Published As

Publication number Publication date
NO176277C (no) 1995-03-08
NO922636L (no) 1989-02-08
DK313388D0 (da) 1988-06-09
CZ392588A3 (en) 1996-11-13
HU203762B (en) 1991-09-30
MY103572A (en) 1993-08-28
EP0294994B1 (en) 1994-05-11
CZ281857B6 (cs) 1997-03-12
EP0294994A1 (en) 1988-12-14
IL86602A0 (en) 1988-11-30
DK313388A (da) 1988-12-11
CN88103539A (zh) 1988-12-28
JPS6413093A (en) 1989-01-17
PL272928A1 (en) 1989-07-10
PT87678A (pt) 1988-07-01
PT87678B (pt) 1992-10-30
PL158994B1 (pl) 1992-10-30
FI890620A (fi) 1989-02-09
NO176277B (no) 1994-11-28
IL86602A (en) 1992-06-21
ATE105561T1 (de) 1994-05-15
DE3889497T2 (de) 1994-08-25
EG18525A (en) 1994-04-30
NO890531L (no) 1989-02-08
DE3889497D1 (de) 1994-06-16
NO890531D0 (no) 1989-02-08
DD281602A5 (de) 1990-08-15
AU593743B2 (en) 1990-02-15
FI89802C (fi) 1993-11-25
IE881733L (en) 1988-12-10
CA1300625C (en) 1992-05-12
FI89802B (fi) 1993-08-13
YU111988A (en) 1989-12-31
NO922636D0 (no) 1992-07-03
IE63214B1 (en) 1995-04-05
WO1988009793A1 (en) 1988-12-15
AU1753588A (en) 1988-12-15
NZ224956A (en) 1990-07-26
MX174093B (es) 1994-04-21
FI890620A0 (fi) 1989-02-09
JPH078874B2 (ja) 1995-02-01
HUT54376A (en) 1991-02-28
US4914101A (en) 1990-04-03
MX11827A (es) 1993-04-01
PH25187A (en) 1991-03-27
CN1019576B (zh) 1992-12-23
KR900006758B1 (ko) 1990-09-20
ZA884115B (en) 1990-02-28
ES2051846T3 (es) 1994-07-01
KR890000500A (ko) 1989-03-15

Similar Documents

Publication Publication Date Title
HUP0000610A2 (hu) Fájdalomcsillapító hatású piperidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
LU88579I2 (fr) ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)
FI954965A (fi) AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään
ES8601978A1 (es) Procedimiento para preparar derivados de isoquinoleina
DE69434198D1 (de) Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten
YU46767B (sh) POSTUPAK ZA DOBIJANJE 3,4-DIHIDRO-2-ALKIL-3-OKSO-N-ARIL-2H-/1/ BENZOTIENO/3,2-e/-1,2-TIAZIN4-KARBOKSAMID-1,1-DIOKSIDA
DK0769296T3 (da) Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
SE8100954L (sv) Nya tioloestrar och forfaranden for framstellning derav
DE3869144D1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
ES8604150A1 (es) Un procedimiento para la preparacion de medicamentos a base de derivados de la 1,4-dihidropiridina
ES446325A1 (es) Procedimiento para preparar tieno-(3,2-c)-piridina y deriva-dos de la misma.
FR2439192A2 (fr) Derives d'oxadiazole-1,2,4 et leur application en therapeutique
HUT63836A (en) Process for producing acridine derivatives
DE3866729D1 (de) 4-chloroxazol-derivate, verfahren zu ihrer herstellung und ihre verwendung.
GR80903B (en) Process for the preparation of novel thieno (2,3-b) pyrrole derivatives
JPS57109791A (en) Thiopyranopyridine derivative
JPS57185259A (en) Azetidinone derivative and its preparation
ES8609254A1 (es) Un procedimiento para preparar un derivado de piridinodicar-boxilato